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Abstract 
Background: There is substantial evidence that psychosocial programs delivered online can 
be effective in treating and preventing mental health problems. However, use of evidence-
based programs in the community is currently suboptimal, and there is a lack of evidence 
around how to increase engagement with existing evidence-based programs.  Novel 
approaches to increasing the acceptability of online programs such as the use of brief 
engagement-facilitation interventions (EFI) require evaluation. 
Aims: The aims of this study are to 1) examine the effectiveness of a brief online 
engagement-facilitation intervention (EFI) presented prior to an online self-help mental 
health program (myCompass) in improving uptake of and adherence to that program, and 2) 
assess if greater uptake and/or adherence are associated with improved efficacy (greater 
reduction in symptoms of depression and anxiety) relative to a control condition). 
Methods: A three-arm randomized controlled trial will be conducted (target sample: N=693 
participants recruited via social media). An active online cognitive behavioral therapy (iCBT) 
intervention will be delivered either with (arm 1) or without (arm 2) the EFI. An attention 
control group (arm 3) will enable testing of the relative efficacy of the iCBT intervention. 
Primary outcomes are uptake of the intervention (initiation) and adherence (module 
completion). 
Results: Findings will inform the more efficient dissemination of a range of psychosocial 
programs into the community, with potential for significant efficiency gains in treating 
common mental health problems. 
Conclusions: Greater engagement with online psychosocial programs may lead to significant 
reductions in the burden of common mental health problems in the community. 
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Introduction 
Depression and anxiety are common mental disorders, with estimated 12-month prevalence 
rates of 5-7% for major depressive disorder and 5-10% for anxiety disorders globally [1-3]. 
Despite high levels of disability and burden, only one-third of people with a mental health 
problem will seek help from a health professional [4]. Lower cost and intensity, evidence-
based alternatives to face-to-face services, such as online mental health (E-MH) programs, 
are increasingly being offered to those at-risk for mental health problems or experiencing 
mild mental illness [5]. 
There is substantial evidence that psychosocial programs delivered online can be effective in 
treating and preventing mental health problems [6]. However, uptake of these programs in the 
community remains suboptimal [7 8]. Previous studies have reported that many people prefer 
face-to-face therapy over E-MH programs [8-10], despite viewing online programs as having 
advantages such as convenience [8]. This preference may be due partly to the common public 
view that online therapies are not as effective as face-to-face therapy [11]. This 
implementation gap undermines the potential for technology to overcome traditional barriers 
to treatment access. While there are initiatives addressing public awareness of online mental 
health programs (e.g., [12]) and new programs are being developed to be more consumer-
centered [13], there remains a lack of evidence around how to increase engagement with 
existing evidence-based programs. 
Barriers to use of E-MH programs 
There are many reported barriers to the uptake of E-MH programs [14]. A previous study 
reported that 52% of the unique visitors to the MoodGYM program (N = 194,840) did not 
register for the program [15]. Among those community-based users who registered (N = 
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82,159), 49% did not engage in a single module of the program. Overall, 10% of community-
based visitors to MoodGYM completed one or more modules, suggesting there may have 
been a considerable proportion who experienced one or more barriers to engaging with the 
program. Reducing these barriers to uptake by a small fraction could have large impacts on 
the number of individuals who receive evidence-based treatment. Studies based in primary 
care have similarly reported rates of uptake between 3% and 25% [16].  
Some of these reported barriers are modifiable. Issues around the barrier of the ‘acceptability’ 
of E-MH programs may be influenced by a number of factors, including low expectations of 
program effectiveness, data security concerns, limited familiarity with E-MH programs, 
negative attitudes towards seeking help in general, and internet anxiety [5 6 9 14 16 17]. Poor 
adherence is also a common feature of E-MH programs, particularly in naturalistic settings 
[15 18]. Low adherence can occur for a number of reasons; some positive such as sufficient 
dosage for remission of symptoms, some neutral such as insufficient need for treatment (e.g., 
healthy users), and some negative, such as poor fit of content to needs, lack of interactivity, 
symptom severity, low motivation, or a lack of improvement [15 18-20]. 
Engagement-Facilitation Interventions (EFIs) 
Challenging barriers prior to the commencement of an E-MH program is anticipated to 
increase engagement. This approach to increasing the acceptability of a program is labelled 
an acceptance-facilitation intervention (AFI) or more broadly, an engagement-facilitation 
intervention (EFI). EFIs contain information presented to the participant that target any 
potential barriers  to engagement that may reduce their use of the program [16]. The use of 
EFIs is grounded in the Theory of Planned Behavior [21], with the aim of changing social 
norms around use of E-MH interventions [22]. Previous research has been mixed for 
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demonstrating an effect for EFIs on acceptance of online programs for pain [23 24], and 
mental health interventions for people with diabetes [25]. One study showed that 
acceptability of E-MH programs for depression increased following presentation of a video-
based AFI in a primary care setting [16]. However, to our knowledge, no previous study has 
examined the utility of an EFI in increasing uptake of and adherence to an existing, publically 
available E-MH program. The current proposed three-armed randomized controlled trial 
(RCT) will provide a robust evaluation of both the EFI and the original online mental health 
program’s effectiveness, while accounting for individual factors that may be associated with 
improved engagement.  
Aims 
1. To test whether delivery of a brief EFI increases uptake of and adherence to an online 
mental health program. 
2. To test whether greater uptake and/or adherence are associated with improved efficacy, as 
indicated by greater reduction in symptoms of depression and anxiety relative to a control 
condition. 
Methods 
Trial design 
A three-arm RCT will test whether an EFI increases uptake of and adherence to an online 
intervention targeting comorbid mental health problems. Participants will be randomly 
allocated to either (1) the active intervention with the EFI (myCompass 2 + EFI); (2) the 
active intervention without the EFI (myCompass 2 Alone); or (3) an attention control 
condition (HealthWatch) matched for time taken to complete. This will enable testing of 
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whether the EFI has an impact on the efficacy of the myCompass 2 program. This study 
protocol addresses the Standard Protocol Items: Recommendations for Interventional Trials 
(SPIRIT) checklist [26]. 
Interventions 
The Engagement-Facilitation Intervention (EFI) 
The pre-intervention EFI consists of brief, tailored material presented on a series of webpages 
to the participant after they are randomized to a condition but before they start the 
intervention for depression and anxiety (myCompass 2). 
The EFI was developed using a series of four focus groups (total n = 24; male = 3, female = 
21) with community members who had personal lived experience of depression and/or 
anxiety. The development of the EFI was informed by the principles of participatory design, 
which are particularly appropriate in implementation research that focuses on the relevance 
and uptake of interventions [27]. The results of the focus groups indicated that the EFI 
material should challenge personal barriers to engagement with psychosocial interventions by 
focusing on feedback about symptoms, information about the content and efficacy of the E-
MH program, normalizing participation in E-MH programs, and brief information on data 
security. The development of the EFI was also informed by theory that emphasizes the 
importance of social norms in the acceptability of online psychosocial programs [16 21 22]. 
The EFI is very brief, and takes approximately five minutes to interact with and read. Brevity 
is essential to ensure that information is easily digestible and does not add a significant 
barrier to the time required to engage with the intervention program itself. 
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The EFI was delivered in a click through linear format, as part of the online platform also 
housing the surveys, and the control group content.  The EFI includes the following 
components: 
1. Graphical feedback about the participant’s symptom levels and a written description 
of the benefits of participating in E-MH programs, tailored to symptom levels. 
2. Written information about the efficacy of the E-MH program. 
3. Written information about the content and time commitment involved with the 
program. 
4. Two testimonials (presented in a single 1 minute video) outlining the benefits of E-
MH programs to provide information and normalize participation in online self-
guided therapy interventions. 
5. Written information about data security. 
myCompass 2 
myCompass 2 is an updated version of the previously evaluated myCompass online program 
[28 29]. It is a fully automated, interactive self-help program (without therapist assistance) 
that is delivered for free via the Internet (see https://www.mycompass.org.au/). myCompass 2 
can be accessed on mobile phones and tablets in addition to computers. The program 
provides people experiencing mild to moderate symptoms of stress, anxiety and/or 
depression, with 24/7 access to a private, personalized and evidence-based treatment 
program. Evidence from two community-based trials (n = 89; n = 720) showed that the 
original version of the myCompass program was able to significantly reduce mental health 
symptoms and improve work and social functioning [28 29]. 
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Similar to the original version, myCompass 2 also contains 14 modules derived primarily 
from cognitive behavior therapy (CBT), with elements of problem solving therapy, 
interpersonal psychotherapy and positive psychology. Seven modules provide core 
transdiagnostic CBT, while the remaining seven are tailored to specific mental health 
concerns (e.g., sleep, communicating clearly) Other features include real-time self-
monitoring of thoughts, feelings and behaviors (via mobile phone or computer); SMS or 
email self-monitoring reminders; graphical feedback about self-monitoring information; and 
helpful facts, mental health-care tips or motivational statements (via SMS or email). Similar 
to the original myCompass program [29], myCompass 2 is tailored to user needs, with 
screening scales used to profile the participant and provide them with recommendations as to 
which modules would be most suitable for them. myCompass 2 is delivered over 7 weeks to 
enable sufficient time to complete all of the available modules. It is expected that users will 
complete two modules per week for 7 weeks, although completion of fewer modules has been 
shown to lead to significant symptom reduction [29 30]. Each module takes 30-45 minutes to 
complete. 
Attention control condition (HealthWatch) 
The attention control condition will consist of 14 brief modules of public domain health and 
lifestyle information unrelated to mental health, that has been matched for time taken to 
complete, and has previously been shown to have high credibility (see, e.g., [31 32]. Module 
topics are: Keeping bones strong and healthy, The dark side of sun exposure, Fight off food 
poisoning, Taking supplements, Keep your kidneys healthy, Your microbes and you, 
Handling household burns, Cold, flu, or allergy?, Healthy heart, Allergens & irritants, Getting 
in straight, The power of your pancreas, Keep an eye on your eyes, Don’t toss the floss!. The 
program will also be delivered over 7 weeks. At the end of the 6-month trial period after all 
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follow-up data has been collected, the control group will be invited to use the myCompass 2 
program. 
Participants and eligibility criteria 
Participants will be recruited online from the general community. To be eligible for the trial, 
potential participants must: 
1) Have current symptoms of depression OR anxiety in the mild to moderate range 
(Patient Health Questionnaire-9 (PHQ-9) OR Generalized Anxiety Disorder-7 (GAD-
7) score at screening of 5-14), and 
2) Be aged 18 years or over and living in Australia. 
Community members will be excluded from enrolling in the trial if they: 
1) Have had any previous use of the myCompass online program. 
2) Are receiving psychological therapy at screening. 
3) Self-report that they have had a suicide plan in the past month. 
4) Self-report that they have a diagnosis of psychosis or bipolar disorder. 
Participants who are not eligible according to the above criteria will be informed following 
the screening and provided with relevant help-seeking resources. 
Recruitment 
Recruitment will be conducted through social media advertising (e.g., Facebook) to ensure a 
broad cross-section of the community is reached and to maintain ecological validity, as online 
interventions are often marketed online directly to consumers. Based on a previous RCT 
conducted by the lead author using a similar social media strategy [31] which recruited an 
10 
 
average of 2.8 participants per day, we anticipate that recruitment targets will be met within 
approximately 9 months for the RCT. Social media advertisements will target adults living in 
Australia, aged 18 years and older, who may be currently experiencing low mood or 
symptoms of anxiety. The advertisement will contain a link to a webpage containing 
information about the study. Participants who click on the advertisement will be taken to the 
information and consent page, where they will be invited to read information about the study 
and to provide their consent to participate online. It is anticipated that recruitment will 
commence during late 2018. The flow of participants through the study is presented in Figure 
1. 
Ethics approval 
The ethical aspects of this research have been approved by The Australian National 
University Human Research Ethics Committee (ANU HREC protocol number 2018/257). 
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 Figure 1. Trial flow chart 
Hypotheses 
We propose the following hypotheses: 
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Primary Hypotheses (Aim 1) 
H1: Uptake (initiation of at least one module) will be higher in the myCompass 2 + EFI 
condition relative to the myCompass 2 Alone condition. 
H2: Greater adherence will be observed (i.e., higher number of modules completed) in the 
myCompass 2 + EFI condition relative to myCompass 2 Alone. 
Secondary Hypotheses (Aim 2) 
H3: Efficacy (reduction in symptoms of depression and anxiety) will be higher in the two 
active myCompass 2 intervention conditions than the HealthWatch attention control condition 
at post-test and 6-month follow-up. 
H4: Efficacy will be higher in the myCompass 2 + EFI condition than the myCompass 2 
Alone condition at post-test and follow-up, and this difference will be mediated by adherence 
to the program. 
Exploratory Hypotheses 
H5: Adherence, uptake and efficacy will be moderated by a range of sociodemographic and 
psychological characteristics including gender, age, cultural/linguistic background, education, 
social support, symptoms of depression and anxiety, acceptability of psychosocial online 
programs, attitudes toward professional psychological treatment, familiarity and use of 
technology, stigma and mental health literacy. 
H6: Secondary indices of efficacy (reductions in suicidality, distress and disability; increases 
in acceptability of internet-based psychosocial interventions and quality of life) will be 
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highest in myCompass 2 + EFI, followed by myCompass 2 Alone, which will outperform the 
HealthWatch attention control condition. 
Outcomes and data analysis 
Primary outcomes 
Uptake (H1) will be assessed as the number of individuals who access at least one therapeutic 
module of the program. Rates of uptake in myCompass 2 + EFI will be compared to uptake in 
the myCompass 2 Alone condition, based on a chi-square test, as complete data on uptake 
will be available for all individuals randomized to the active conditions. Online usage data is 
automatically collected by the myCompass 2 program for each user. Adherence (H2) will be 
based on the number of modules completed of myCompass 2 by the post-test survey. 
Adherence is a complex outcome, as individuals may discontinue a program for many 
reasons, such as receiving adequate dosage, lack of engagement, low motivation for change, 
or low need (few symptoms) [15]. We have chosen the definition of number of modules 
completed as it captures the dosage of therapeutic content received. We will explore 
secondary indices of adherence (e.g., percentage of users completing one/half/all modules) 
for consistency of outcomes, and examine self-reported reasons for non-adherence. To test 
the effect of the EFI on adherence, module completion in myCompass 2 + EFI will be 
compared to module completion in the myCompass 2 Alone condition using a Mann-Whitney 
test, based on usage data as above. 
Secondary outcomes 
Efficacy (H3, H4) will be assessed on the basis of reduced symptoms of depression (PHQ-9, 
[33]) and generalized anxiety (GAD-7, [34]) at post-test and 6-month follow-up. 
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Comparisons of efficacy will be made between participants in each of the active intervention 
conditions and those in the attention control condition. 
Secondary efficacy outcomes (H6) will also be examined, including effects on acceptability 
of internet-based psychosocial interventions [16], general psychological distress using the 
Distress Questionnaire-5 (DQ5, [35]), suicidal ideation using the Psychiatric Symptom 
Frequency (PSF) scale [36]), disability/days out of role, and quality of life (EUROHIS-QOL 
8; [37]). 
Analysis of the relative efficacy of the myCompass 2 + EFI condition to the myCompass 2 
Alone condition (H4) will be conducted with respect to change over time (pre-test to post-test 
and pre-test to follow-up) relative to the control condition. Intention-to-treat analyses will be 
conducted using mixed model repeated measures analyses, conservatively estimated using 
unstructured covariance matrices. These models incorporate all available data, including 
participants with missing data points, under the missing-at-random assumption without using 
biased techniques such as last observation carried forward [38]. These models also account 
for within-individual variability in testing observed effects. 
Predictors of these outcomes (uptake, adherence and efficacy; H5) will be assessed at 
baseline and include gender, age, cultural/linguistic background, education, self-reported 
history of psychological treatment and diagnosed mental illness, symptoms of depression and 
anxiety (PHQ-9, [33]; GAD-7, [34]), social support (Schuster Social Support Scale [39]), 
personality profile (Big 5 – Mini-IPIP [40]), acceptability of internet-based psychosocial 
programs [16], perceptions of online therapy (brief PCTQ-P, [41]), attitudes toward 
professional psychological treatment (ATSPPH-SF, [42 43]), and depression stigma and 
literacy [44]. 
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Analyses for H5 will be published separately to the main analyses, and involve logistic 
regression models for uptake and negative binomial regression models for adherence 
(accounting for inflated zeros and skewness of module completion), accounting for 
intervention condition. In addition, growth mixture models will be used to model response to 
the intervention (efficacy), classifying participants into multiple latent classes based on their 
patterns of symptom change over time. Predictors of class membership will then be tested 
using multinomial logistic regression models to ascertain which characteristics are associated 
with response to the intervention, adjusting for intervention condition. 
Trial delivery 
The trial will be delivered using the digital infrastructure of the Black Dog Institute, Sydney, 
Australia. The infrastructure enables computer-generated random allocation, and automatic 
assessments, intervention materials and reminders to be delivered seamlessly to participants 
using a single login. 
Data collection 
Eligible participants will be asked to provide an e-mail address and complete a baseline 
questionnaire. Following completion of the baseline questionnaire, participants will be 
randomized to one of the three conditions, using computer-based randomization stratified on 
symptom severity (as measured by the DQ5 [35] at baseline), age, and gender (permuted 
block randomization, block size of 6 within each stratum) to ensure balance across conditions 
using a computerized randomization algorithm embedded into the trial portal. The 
intervention period will run for 7 weeks during which time participants will be able to access 
their assigned program as much or as little as they like. Participants will receive an automated 
weekly reminder e-mail to encourage them to engage with the active intervention website 
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(Conditions 1 and 2) or the attention control website (Condition 3). Assessments will occur at 
baseline, post-intervention, and at 6 months post-intervention. Participants will receive a 
reminder to complete the questionnaire if they have not done so after 1 and 2 weeks. The trial 
will be effectively double-blinded. Participants will be blinded to whether they are receiving 
the active intervention or the attention control intervention – they will only be informed that 
they will be randomized to receive one of three programs: (1) strategies for challenging 
unhelpful thoughts and behaviors, (2) education about online interventions plus program (1), 
or (3) general health and lifestyle information. They will not be provided with information 
about which of these interventions is expected to be the most effective. The statistician 
performing the analyses will be blinded to condition allocation. Assessments will also be 
blinded, as they are entirely based on self-report. Table 1 presents the measures for the trial 
and the assessment time points.  
Table 1. Assessment time points 
Construct Measure Screening Baseline Post-survey 
Follow-up 
survey 
Depression symptoms PHQ-9 X  X X 
Anxiety symptoms GAD-7 X  X X 
Gender --  X   
Age --  X   
Language spoken at home  --  X   
Education --  X   
Employment status   X   
Region/area of residence   X   
Social support  Schuster Social Support Scale  X   
Personality inventory Big 5 (mini-IPIP)  X   
Acceptability of internet-
based psychosocial programs UTAU  X X X 
Perceptions of online therapy  Brief PCTQ-P  X   
Attitudes toward professional 
psychological treatment  ATSPPH-SF  X   
History of psychological 
treatment Self-report  X   
History of diagnosed mental 
illness Self-report  X   
Depression stigma DSS- Personal stigma scale  X   
Depression literacy D-Lit  X   
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General psychological distress  DQ5  X X X 
Suicidal ideation  PSF  X  X 
Disability/days out of role --  X X X 
Quality of life  EURO-HIS 8  X X X 
 
Measures 
Demographic characteristics and history of mental illness/psychological treatment  
The following demographic characteristics will be assessed: gender (male, female other), age 
(18-25, 26-35, 36-45, 46-55, 56-65, 66+), language spoken at home (English only, English 
and another language, another language only), level of education (primary school, some 
secondary school/year 10 equivalent, year 12, Certificate Level I-IV, Diploma/Associate 
degree, Bachelor degree, Graduate Diploma/Graduate Certificate, Masters degree, Doctoral 
degree), employment status (full-time, part-time/casual, unemployed, not working due to 
studying/maternity leave, retirement, etc.), and region/area of residence (metropolitan area, 
regional area, rural/remote area). History of mental illness and psychological treatment will 
be assessed by the following items developed by the researchers: “Have you ever in your life 
been diagnosed with any of the following disorders:” (list of 10 possible disorders provided, 
with an option to list an ‘other’ mental disorder if not on the list) and “Have you ever in your 
life participated in psychological treatment for any psychological problem (e.g., with a 
psychologist, psychiatrist, counsellor, mental health nurse, general practitioner etc.)?” 
(Yes/No) 
Depression symptoms 
Depression symptoms will be assessed using the PHQ-9 [33]. This scale consists of 9 items 
assessing the frequency of DSM-IV symptoms of Major Depression in the past two weeks. 
Items are rated on a 4-point scale ranging from not at all to nearly every day, and item scores 
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are summed to produce an overall severity score ranging from 0-27, with higher scores 
indicating higher symptom severity. The PHQ-9 has good sensitivity and specificity for 
detecting major depression in both clinical and general population samples and has been 
shown to detect change over time [45]. 
Anxiety symptoms 
Anxiety symptoms will be measured by the GAD-7, a scale comprising seven items that 
correspond to DSM-IV and DSM-5 criteria for generalized anxiety disorder [34]. Items are 
rated on the same 4-point scale as the PHQ-9, and summed scores on the GAD-7 range from 
0-21, with higher scores indicating greater symptom severity. Studies have demonstrated that 
the GAD-7 has good psychometric properties in general population samples, with accuracy 
against clinical diagnosis [45 46]. 
Social support 
The Schuster Social Support scale will be used to measure the quality of the participants’ 
important social relationships [39]. The scale contains 15 items in total, with three 5-item 
subscales assessing the extent of supportive and negative social interactions with a 
respondent’s family, friends, and spouse. Only the family and friend subscales (10 items in 
total) will be used in this study. Items are rated on a 4-point scale ranging from often to never. 
Example items include: “[How often do your friends] make you feel cared for?” and “[How 
often do your family] criticize you?” This scale has shown adequate reliability in a 
community-based sample [39].  
Personality 
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Personality characteristics will be assessed using the Mini-IPIP, a 20-item version of the 
larger International Personality Item Pool [40]. The scale contains 4 items assessing each of 
the Big Five personality traits: Extraversion (example item: “I am the life of the party”), 
Agreeableness (example item: “I sympathize with others’ feelings”), Conscientiousness 
(example item: “I get chores done right away”), Neuroticism (example item: “I have frequent 
mood swings”), and Intellect/Imagination/Openness (example item: “I have a vivid 
imagination”). Respondents are asked to rate the personal accuracy of each item on a 5-point 
scale ranging from very inaccurate to very accurate. The scale shows acceptable internal 
consistency, and convergent, discriminant, and criterion-related validity [40].  
Acceptability of internet-based psychosocial programs 
Acceptability of internet-based programs will be assessed using items developed and/or 
compiled by Ebert and colleagues, based on the Unified Theory of Acceptance and Use of 
Technology (UTAUT) [16]. Ebert and colleagues developed four items to measure 
acceptance, each rated on a 5-point scale ranging from totally disagree to totally agree. An 
example item is: “If I was suffering from psychological strain such as enduring lowered 
mood, loss of interest and lowered energy, sleeping problems, rumination, loss of joy in 
life…I could imagine trying out an Internet-based intervention for mental health problems”. 
Scores are summed (range = 4-20), with higher scores indicating higher acceptance. These 
items were demonstrated by Ebert and colleagues to have acceptable internal consistency 
[16]. Ebert and colleagues also developed eight further scales to measure additional 
constructs for facilitators and barriers of acceptance. We selected the following three scales 
for this study: performance expectancy (4 items drawn from Wilson and Lankton [47] and 
Schomerus and colleagues [48], example item: “Using an Internet-based training would 
reduce my mental health problems”), effort expectancy (3 items, also drawn from [47] and 
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[48], example item: “Using an Internet-based depression intervention would be an easy task 
for me”), and concerns regarding data security (2 items, developed by Ebert and colleagues, 
example item: “When participating in an online-training I would trust, that all information I 
disclose would be treated in strict confidence”. These items are rated on the same 5-point 
scale described above.   
Perceptions of online therapy 
Perceptions of online therapy will be assessed using 12 items from the original 39-item 
Perceptions of Computerized Therapy Questionnaire-Patient Version (PCTQ-P) [41]. The 
number of items was reduced in order to minimize respondent burden, and items were 
excluded on the basis of factor loadings, balanced with the need to retain sufficient variability 
within subscales of the measure. The measure contains five subscales designed to measure 
different characteristics that have been shown to influence adoption of online therapy: 
relative advantage (example item: “I like that computerized therapy is anonymous”), 
compatibility (example item: “I have a positive attitude about computerized therapy”), 
complexity (example item: “It is easy to use computerized therapy”), observability (example 
item: “I have heard of computerized therapy before now”), and future use intentions (example 
item: “I plan to use computerized therapy in the future”). Items are rated on a 7-point scale 
ranging strongly agree to strongly disagree. Strong reliability has been demonstrated for total 
and subscale scores of the overall PCTQ-P [41].       
Attitudes towards professional psychological treatment 
The attitudes of respondents to seeking professional psychological treatment will be 
measured using five items from the short form of the Attitudes Towards Seeking Professional 
Psychological Help scale (ATSPPH-SF [43]) with updated language and wording [42]. Based 
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on factor loadings from previous research conducted by the current study author on the 
original ATSPPH-SF scale, many items (particularly reverse-scored items) did not load very 
well on a single factor. Thus, for simplicity the reverse coded items were removed, with the 
remaining five items retained (1, 3, 5, 6, 7). This scale asks respondents to agree with 
statements about psychological treatment using a 4-point Likert scale (0=Disagree, 3=Agree). 
Scores range from 0-30, with higher scores indicating more positive attitudes towards seeking 
professional help. Example items include “If I was having personal or emotional problems, 
the first thing I would do is seek professional help”, and “A person with an emotional 
problem is not likely to solve it alone; he or she is likely to solve it with professional help”. 
The 10-item short-form scale has demonstrated sound psychometric properties in previous 
research [42 43 49]. 
Depression stigma 
The Personal Stigma Subscale of the Depression Stigma Scale (DSS-PSS, [50]) will measure 
the personal stigma respondents have experienced in relation to their own attitudes towards 
depression. Items include “People with depression could snap out of it if they wanted”, 
“Depression is not a real medical illness”, “If I had depression, I would not tell anyone”. 
Respondents are asked to indicate their level of agreement with each of 9 statements about 
depression using a 5-point Likert scale (0=strongly disagree, 4=strongly agree). Higher scores 
indicate higher levels of personal stigma about depression. The DSS-PSS has demonstrated 
good internal consistency, test-retest reliability, and convergent validity [50]. 
Depression literacy 
The level of literacy for depression will be measured using the short form of the Depression 
Literacy questionnaire (D-LIT, [44]); an 11-item scale with high internal consistency and 
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test-retest reliability. Items ask respondents to indicate true/false/don’t know in relation to 
statements about the nature, detection, symptoms, and treatment of depression. Example 
items include “People with depression often speak in a rambling and disjointed way”, 
“Depression does not affect your memory and concentration”, and “Clinical psychologists 
can prescribe antidepressants”. Scores range from 0-11, each correct response scores 1 point, 
with higher scores indicating higher depression literacy [44]. 
General psychological distress  
The Distress Questionnaire-5 (DQ5, [35]) will measure general psychological distress. Five 
items ask respondents to indicate the frequency with which they have experienced a range of 
distressing situations, thoughts, and feelings over the previous 30 days using a 5-point Likert 
scale (1=Never, 2=Rarely, 3=Sometimes, 4=Often, 5=Always). Example items include: “My 
worries overwhelmed me”. “I felt hopeless”, and “I found social situations upsetting” [35]. 
Total scores range from 5-25, with higher scores indicating more severe levels of 
psychological distress. The DQ5 has demonstrated high internal consistency and external 
validity, low response burden, and high sensitivity and specificity for identifying caseness for 
psychiatric disorder using a cutoff of 11 [35 51]. 
Suicidal ideation 
Suicidal ideation will be measured using the five suicide-specific items from the Psychiatric 
Symptom Frequency Scale (PSF [36]). These items measure both suicidal ideation and 
suicidal behavior in the previous 12 months, using items covering thoughts, plans, and 
attempts in relation to suicide. Participants indicate yes/no to indicate whether any of these 
aspects of suicide ideation or behavior have been present in the previous 6 months, with 
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higher scores indicating higher severity of suicidal ideation and actions. The suicide items of 
the PSF have demonstrated high internal reliability and validity [36]. 
Disability/days out of role 
Disability and days out of role will be assessed by two open-ended questions, the first 
assessing days out of role: “In the last 30 days, how many days were you totally unable to 
work, study, or manage your day-to-day activities because of emotional problems (such as 
feeling depressed or anxious)?” and the second assessing disability “Aside from those days, 
in the last 30 days, how many days were you able to work, study, or manage your day-to-day 
activities but had to cut back on what you did or did not get as much done as usual because of 
emotional problems?”. 
Quality of life 
Quality of life will be assessed using the EUROHIS-QOL 8-item index (EUROHIS-8; [37]). 
The EUROHIS-8 is composed of eight items designed to measure the psychological, 
physical, social, and environmental aspects of quality of life. Example items include: “How 
would you rate your quality of life?” and “How satisfied are you with your ability to perform 
your daily activities?” Responses are scored on a 5-point scale, with response categories 
ranging from very dissatisfied to very satisfied, very poor to very good, and not at all to 
completely. Item responses are summed, producing a total score ranging from 0 to 32, with 
higher scores indicating higher quality of life. Studies have demonstrated sound internal 
consistency for the EUROHIS-8 in multiple samples [37 52].  
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Power and recruitment 
For primary hypothesis H1, to detect increases in uptake from 50% to 65% (a conservative 
baseline based on previous research [53]), with conservative increase based on previous work 
by Ebert et al. [16] with 90% power requires a sample of 231 per condition (with α = .05). To 
detect increases in adherence (H2), assuming a small effect of f = 0.19 (the estimated median 
effect from previous research [53]) between active conditions requires a sample of 111 per 
condition. 
For secondary hypotheses (H3-4), a sample of 110 per condition is required to find a small 
effect size of f = 0.18 (based on a previous study by Proudfoot et al. [29]) between active 
conditions relative to control over the three assessment time points (baseline, post, and 6 
month follow-up) with 90% power (α = .05, r = 0.5 between repeated measures). Allowing 
for up to 30% attrition from post-test assessments indicates a target sample of 158 per 
condition will be required. Based on the largest estimate of N required (n = 231 per 
condition), we aim to recruit a sample of N = 693. 
Incentives 
Small incentives in the form of online (e-) gift cards will be given to all participants for 
completion of each assessment conducted online, irrespective of condition and irrespective of 
their level of engagement with the intervention. One e-gift card ($15) will be given on 
completion of the post-test survey and another ($25) at completion of the follow-up survey. 
These incentives are compensation for the participant’s time to fill in each survey, and will 
assist in maximizing the data available to test efficacy outcomes. Only participants who 
complete the survey at each assessment will receive the e-gift card. Participants will be 
emailed an e-gift card following the completion of each survey. 
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Quality assurance and monitoring 
The project manager will work closely and have regular contact with other members of the 
research team to monitor the progress of the project. The project manager will also have 
regular contact with the IT staff at the Black Dog Institute to ensure that the online trial 
delivery platform is performing as expected. Screening and program uptake will be 
monitored closely. 
Ethical concerns 
Ethical concerns relevant to the present study relate predominantly to the use of internet-
based interventions. These include the online storage of data, managing privacy of personal 
information, obtaining consent to participate, providing opportunities to exit the study, and 
ensuring any distressed participants in the study are provided with appropriate assistance. 
These issues are addressed below.  
Data storage and privacy 
We will ensure the privacy of online data through password protected computers, and a 
secure portal for online data collection and delivery of the EFI and the E-MH program 
(myCompass 2). Participant survey data will be assigned an identification code, and stored 
separately from personal information (e-mail addresses). Informed consent will be provided 
through an information web page. The online consent process will require participants to 
answer a question indicating that they wish to consent to participate in the study. Participants 
who do not consent can close the webpage and will not proceed any further. Participants who 
complete the screening measures and are not eligible to proceed will be provided with a 
webpage thanking them for their interest in the study and offering help-seeking information. 
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Participant withdrawal and distress 
Participants will be informed at each assessment point that they can withdraw from the study 
at any time. If a participant requests to have their data removed from the study, the principal 
investigator will action this request. Any participants who contact the research team in 
distress will be followed-up by a registered psychologist, who will provide support and 
referral to other services as necessary, including general practitioners, and crisis support 
services (e.g., Lifeline). Participants will also be encouraged throughout their participation in 
the project to seek help if they are experiencing any distress, with contact information for 
appropriate resources provided repeatedly. Participants who endorse anything other than “not 
at all” to the question “Thoughts that you would be better off dead, or of hurting yourself” on 
the PHQ-9, or endorse any item on the PSF will be provided with referral information to 
contact Australian telephone crisis services (i.e., Lifeline, and the Suicide Call Back Service). 
Informed consent 
All participants will be provided with a participant information sheet they can print out or 
save when invited to take part in the study. Informed consent will be provided via a web 
page. The online consent process will require participants to answer a question indicating that 
they have read and understood the participant information sheet and provide consent to 
participate in the study.  
Data management  
All data files and databases will be stored for at least 5 years from the time of all 
publications. The data will be stored on a secure server with access restricted to authorized 
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personnel (the project team and IT support staff responsible for managing the server). Email 
addresses and data will be stored separately. 
Dissemination 
Results of the research will be submitted for publication in relevant academic journals and 
mental health conferences. Results will also be summarized on the lead researcher’s 
university website. A plain language summary will be provided to participants who request 
additional information. 
Discussion 
The current protocol describes a randomized controlled trial of an Engagement-Facilitation 
Intervention designed to increase uptake and adherence to an online intervention. There are 
many existing online psychosocial interventions that are effective for reducing symptoms of 
mental and physical health problems. However, their impact is stymied by poor engagement: 
uptake is low and adherence is suboptimal. If the current brief EFI is shown to increase 
uptake and adherence, the resultant elevated rates of community members benefiting from 
use of a broad spectrum of evidence-based treatments may have a considerable effect on the 
health of the population. The EFI model is readily transferable to a range of health and social 
programs, with potential for significant impact in increasing the dissemination of such 
interventions. 
Limitations and risks 
There are several potential limitations or risks associated with the current study. Firstly, there 
is the potential for not meeting recruitment targets as stated and the trial remaining 
underpowered. However, as discussed, this scenario is unlikely given previous studies we 
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have conducted using similar populations and recruitment methods. In addition, the use of 
incentives for assessments and the availability of usage data for all participants will further 
mitigate against this possibility. A further limitation is that we are not prescribing the pace for 
the completion of the myCompass 2 program; therefore participants may complete any or all 
parts of the program during a less than apt timeframe (e.g., all during the first or last week of 
the study). However, this is also a strength of the current study as it enables the study to 
maintain ecological validity and will provide valuable data on how the intervention is used in 
a real world setting. Assumptions around adherence to the intervention may be inaccurate. 
However, to account for a broad range of adherence levels, the power calculations assume 
50% adherence in the control group – lower or higher rates of adherence would increase 
power to detect a 15% difference in adherence for the intervention groups. Finally, the 
elements of the EFI were selected through a systematic process that accounted for existing 
empirical findings around uptake and adherence, along with qualitative data collected from 
focus groups with individuals with lived experience of anxiety or depression. Nevertheless, 
other elements might be more persuasive in changing usage of such interventions, and the 
design of the EFI may also influence its impact. 
Conclusion 
This research has potential to have a significant impact on uptake and adherence, not only for 
online mental health programs, but psychosocial interventions more broadly. In particular, if 
the EFI is shown to be effective in increasing uptake of the intervention, potential 
implications at a population level are considerable. For example, if broadly implemented, a 
15% increase in the number of Australians using evidence-based interventions may result in 
up to 600,000 additional individuals benefiting from e-mental health programs for anxiety or 
depression each year. The potential in countries with lower uptake of these interventions is 
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even greater. This model of engagement, if effective, is readily transferrable to other types of 
interventions and could be adopted immediately for a broad range of online and face-to-face 
psychological and social programs. There are effective psychosocial programs to reduce or 
manage the symptoms of an increasing number of mental and physical health problems. Even 
a small increase in the uptake of these programs across the community could potentially have 
an immense public health impact, with more individuals accessing evidence-based treatments 
and accessing more efficient tools to manage their symptoms. 
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